Arrevus is a clinical-stage biotechnology company developing novel therapies for orphan diseases. Our mission is to develop therapeutics for unmet medical needs in areas with high treatment failure rates, few therapeutic options, and serious outcomes. Arrevus is advancing ARV-1801, a Phase III clinical program targeting cystic fibrosis pulmonary exacerbations. Arrevus is also advancing preclinical programs to address unmet needs in oncology and antimicrobial resistance.
View Top Employees from ArrevusWebsite | http://www.arrevus.com |
Revenue | $9 million |
Funding | $1 million |
Employees | 3 (3 on RocketReach) |
Founded | 2017 |
Address | Lynn Road, Raleigh, North Carolina 27612, US |
Phone | (919) 588-3727 |
Technologies |
JavaScript,
HTML,
PHP
+19 more
(view full list)
|
Industry | Biotechnology, Biotechnology Research, Pharmaceuticals, Healthcare, Science and Engineering, Drug Manufacturing & Research, Pharmaceutical, Health Care |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies, NAICS Code 541 Companies |
Looking for a particular Arrevus employee's phone or email?
The Arrevus annual revenue was $9 million in 2023.
3 people are employed at Arrevus.
Arrevus is based in Raleigh, North Carolina.
The NAICS codes for Arrevus are [54, 54171, 5417, 541714, 541].
The SIC codes for Arrevus are [873, 87].